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Abstract Members of the caspase family are essential execu-
tors of apoptosis. Caspase-2 has two messenger RNAs generated
by alternative splicing, which encode caspase-2L and caspase-2S.
Although caspase-2L induces apoptosis, caspase-2S also has the
ability to antagonize cell death. Experiments in caspase-2-
deficient mice showed that caspase-2 functions to delay cell death
in some neuronal populations, suggesting that caspase-2S
dominantly acts for cell survival in the brain. However, the
mechanism of caspase-2S-mediated anti-apoptotic effect is still
unclear. Here, we isolated a protein that interacts with caspase-
2S, designated as Ich-1S (caspase-2S)-binding protein (ISBP),
by yeast two-hybrid screening using full-length caspase-2S
cDNA as a bait. ISBP is identical to the recently isolated
calcium and integrin-binding protein, and a small molecule
calcium-binding protein with two EF-hand motifs of its C-
terminus. In vitro transcribed and translated ISBP interacts
specifically with glutathione-S-transferase-fused caspase-2S.
Moreover, the interaction between ISBP and caspase-2S was
observed in cultured cells. Northern blot analysis indicated that
ISBP may be a ubiquitous protein. Interestingly, ISBP can
partially inhibit the processing of pro-caspase-2L induced by
anti-Fas antibody-treated Jurkat cytosolic lysates. These results
suggested that ISBP may be the mediator for the survival
function of caspase-2S.
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1. Introduction
Apoptosis or programmed cell death is an essential process
for normal development and homeostasis of multicellular or-
ganisms. Genetic analyses in the nematode Caenorhabditis ele-
gans characterized several genes, including ced-3, ced-4 and
ced-9, which are involved in programmed cell death [1]. The
ced-3 and ced-4 genes are required for cell death to occur,
while ced-9 antagonizes the function of ced-3 and ced-4 by
protecting cells from programmed cell death [2,3]. Interleukin-
1L-converting enzyme (ICE) was the ¢rst identi¢ed mamma-
lian homologue of CED-3, which is a cysteine protease that
converts the inactive form of interleukin-1L to its biologically
active form [4,5]. To date, 14 mammalian homologues of
CED-3, the caspases, have been identi¢ed and classi¢ed into
three groups based on their homology, structure and substrate
speci¢city [6,7]. Caspases are synthesized as proenzymes and
are proteolytically activated in response to various cell death
signals or by other members of the caspase family. These
results suggested that caspases constitute a protease cascade
[8^11].
Nedd-2 was initially identi¢ed as a gene that is highly ex-
pressed during early embryonic brain development and is
down-regulated in the adult brain, and was later shown to
encode the rodent homologue of the human ICE family mem-
ber Ich-1/caspase-2 [12^14]. Caspase-2 (Nedd-2/Ich-1) has
been implicated in apoptosis. Overexpression of Nedd-2/Ich-
1 causes apoptosis in various cell types [13,14] and decreases
in Nedd-2 expression level caused by an antisense construct
delayed onset of apoptosis induced by trophic factor with-
drawal [15,16]. Caspase-2 is also activated in response to var-
ious apoptotic stimuli such as DNA damage, anti-Fas anti-
body, nitric oxide, hypoxia and ceramide [17^21]. Two
di¡erent mRNA species derived from alternative splicing en-
code two proteins, caspase-2L (Ich-1L) and caspase-2S (Ich-
1S). Caspase-2L has homology to both p20 and p10 subunits
of ICE, but Caspase-2S is a truncated protein containing only
the p20 subunit. Interestingly, overexpression of Caspase-2L
induces apoptosis, while that of Caspase-2S can antagonize
cell death [14]. Experiments using caspase-2-de¢cient mice
showed that oocytes or B lymphoblasts in mutant mice are
resistant to cell death following treatment with chemothera-
peutic drugs or mediated by granzyme B and perforin, while
cell death of some neuronal populations is accelerated in casp-
ase-2-de¢cient mice [22]. These results suggested that casp-
ase-2 may act as both a positive and negative regulator of
programmed cell death, depending on cell lineage and stage
of development, and caspase-2S may dominantly function as a
cell survival e¡ector in the brain.
We have isolated a protein, designated as Ich-1S-binding
protein (ISBP), that interacts with caspase-2S (Ich-1S) using
the yeast two-hybrid system. This protein is ubiquitously ex-
pressed and identical to the recently isolated calcium and in-
tegrin-binding protein (CIB) containing two EF-hand motifs
in its C-terminus [23]. ISBP has the ability to partially sup-
press the processing of caspase-2L in vitro. Thus, ISBP may
be involved in caspase-2S-mediated cell survival.
2. Materials and methods
2.1. Yeast two-hybrid screening
The full-length caspase-2S (Ich-1S) cDNA was ampli¢ed by poly-
merase chain reaction (PCR) from corresponding plasmid constructs,
which were kindly provided by Dr. Miura (Osaka University) and
cloned into the yeast GAL4 DNA-binding domain vector pAS2-1
(Clontech). The resulting construct was used as bait to analyze human
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fetal cDNA libraries (Clontech) according to the Matchmaker two-
hybrid system 2 protocol (Clontech).
2.2. Generation of glutathione-S-transferase (GST) fusion protein and
in vitro translated protein
Full-length caspase-2S (Ich-1S) and ISBP cDNAs were cloned into
the pGEX 6P vector (Pharmacia). The GST fusion protein was puri-
¢ed by glutathione-Sepharose a⁄nity column chromatography (Phar-
macia) according to the manufacturer’s protocol. To cleave the ISBP
protein from GST fusion protein, GST fusion ISBP protein was in-
cubated with 20 U of PreScission protease (Pharmacia).
[35S]Methionine-labeled ISBP and caspase-2L protein were generated
with a TNT T7 Coupled Reticulocyte Lysate system (Promega) ac-
cording to the manufacturer’s instructions.
2.3. In vitro binding assay
Aliquots of 4 Wg of GST or GST fusion caspase-2S protein were
incubated with 35S-labeled ISBP in NETN bu¡er (20 mM Tris^HCl,
pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.01% NP-40, 0.1% BSA) for
2 h and then incubated with 20 Wl of 50% glutathione-Sepharose
beads (Pharmacia) for 2 h. The beads were then washed ¢ve times
with NETN bu¡er. Proteins on the beads were fractionated by 12%
sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and visualized using a Fujix BAS 2000 (Fuji).
2.4. Interaction between ISBP and caspase-2S in vivo
The cDNAs encoding full-length ISBP and caspase-2S tagged with
an HA and a FLAG epitope at the N-terminal end were constructed
by PCR, respectively. They were subcloned into the mammalian ex-
pression vector pCR3.1, generating pCR3.1-HA-ISBP and pCR3.1-
FLAG-caspase-2S. 2 Wg of HA-tagged ISBP and FLAG-tagged cas-
pase-2S were co-transfected into NIH-3T3 cells by using E¡ectene
transfection reagent (Qiagen) [24,25]. 48 h after transfection, lysates
from NIH-3T3 cells were immunoprecipitated with anti-HA antibody
(Santa Cruz) or rabbit normal IgG. The immunoprecipitates were
then separated by SDS^PAGE (15%) and immunoblotted with anti-
FLAG antibody M2 as described [24,25].
2.5. Northern blot analysis
Northern blot analysis of human multiple tissue blots (Clontech)
was performed according to the manufacturer’s instructions, using the
full-length ISBP cDNA or L-actin cDNA as a probe.
2.6. Preparation of Jurkat cytosolic lysates
Jurkat cells (1U107/ml) were treated with 250 ng/ml of anti-Fas
monoclonal antibody CH-11 (MBL) for 4 h, and cytosolic lysates
were prepared as described [18]. Brie£y, cells were washed twice
with ice-cold RPMI 1640 medium and suspended in 400 Wl of extrac-
tion bu¡er (10 mM HEPES^NaOH, pH 7.4, 50 mM NaCl, 2 mM
MgCl2, 5 mM EDTA, 1 mM dithiothreitol (DTT), 40 WM L-glycer-
ophosphate). After four cycles of freezing and thawing, cell lysates
were centrifuged at 12 000Ug for 15 min at 4‡C and then further
centrifuged at 100 000Ug for 1 h at 4‡C. The resulting supernatant
was used as the cytosolic fraction.
2.7. In vitro cleavage assay
In vitro translated 35S-labeled caspase-2L was incubated with anti-
Fas antibody-treated Jurkat cytosolic lysates in reaction bu¡er (20
mM Tris^HCl, pH 7.4, 10 mM DTT, 0.1 mM EDTA) for the indi-
cated times at 30‡C in the presence or absence of 5 Wg ISBP protein,
and the reaction was terminated by addition of 5USDS sample bu¡er.
Samples were subjected to 15% SDS^PAGE and visualized using a
Fujix BAS 2000 (Fuji).
3. Results
3.1. Isolation of cDNA clones encoding ISBP
We screened a human fetal brain cDNA library constructed
in pACT2 plasmid encoding the GAL4 activation domain
using caspase-2S full-length cDNA as bait, because caspase-
2S is highly expressed in the embryonic brain [14]. From ap-
proximately 1U106 transformants, six positive clones were
obtained as determined by activation of his and lacZ reporter
genes. Sequence analysis revealed that these six clones were
identical, and the clone was designated as ISBP. Database
searches utilizing the BLAST program showed that ISBP is
identical to the CIB recently isolated from a human fetal liver
cDNA library by yeast two-hybrid system using the cytoplas-
mic domain of KIIb as bait [23]. CIB consists of 191 amino
acids with a molecular mass of about 25 kDa and is a small
molecule calcium-binding protein with two EF-hand motifs of
its C-terminus. To con¢rm that full-length ISBP interacts spe-
ci¢cally with caspase-2S, full-length ISBP cDNA was ampli-
¢ed by reverse transcriptase-PCR from total RNA of Jurkat
cells, cloned into the pACT2 vector and re-transformed into
the yeast Y187 strain with an empty pAS2-1 vector, a pAS2-1
hybrid with a caspase-2S insert, or a pAS2-1 hybrid with a
caspase-2L (Fig. 1A). ISBP interacted only with the pAS2-1
hybrid with caspase-2S, but neither pAS2-1 empty vector
Fig. 1. Interaction between ISBP and caspase-2S in vitro and in
vivo. (A) The expression vector encoding ISBP fused to the GAL4
DNA activation domain was co-transformed with empty vector, ex-
pression vector encoding caspase-2S or caspase-2L fused with the
GAL4 DNA-binding domain in yeast Y187 cells. Each transformant
was assayed for L-galactosidase activity. (B) In vitro interaction of
ISBP with caspase-2S. In vitro translated [35S]ISBP was incubated
with GST alone or puri¢ed GST fusion caspase-2S protein and
processed as described in Section 2. (C) In vivo interaction of ISBP
with caspase-2S. NIH-3T3 cells were transiently transfected with
HA-ISBP and FLAG-caspase-2S. Cell lysates were prepared and im-
munoprecipitated as described in Section 2. Then, the immunopre-
cipitates were analyzed by Western blotting using anti-FLAG anti-
body M2.
FEBS 23490 23-3-00
A. Ito et al./FEBS Letters 470 (2000) 360^364 361
alone nor pAS2-1 hybrid with caspase-2L, indicating a true
positive interaction of ISBP with caspase-2S. CIB shares ho-
mology with calcineurin B, the regulatory subunit of protein
phosphatase 2B (28% identity, 58% homology) and calmodu-
lin (27% identity, 55% homology) [23]. To investigate the pos-
sibility that caspase-2S can also interact with calcineurin B,
calcineurin B cDNA was cloned into the pACT2 vector and
transformed into the yeast Y187 strain with a pAS2-1 hybrid
with a caspase-2S insert. Calcineurin B failed to interact with
caspase-2S (data not shown).
3.2. Association of ISBP with caspase-2S in vitro and in vivo
We performed an in vitro binding assay to con¢rm the
speci¢c interaction of caspase-2S with ISBP that was observed
in the two-hybrid system. GST and GST fusion caspase-2S
protein were tested for interaction with 35S-labeled ISBP pro-
tein generated by in vitro transcription and translation. As
shown in Fig. 1B, GST fusion caspase-2S protein but not
GST associated with ISBP. In addition to binding ISBP in
vitro, we next investigated the possibility that ISBP also in-
teracts with caspase-2S in vivo. NIH-3T3 cells were transiently
transfected with HA-tagged ISBP and FLAG-tagged caspase-
2S. The ability of caspase-2S to associate with ISBP in mam-
malian cells was assessed by determining whether the two
proteins co-immunoprecipitate. Transfection of NIH-3T3 cells
with caspase-2S and ISBP led to the interaction as demon-
strated by the co-immunoprecipitation of ISBP with caspase-
2S using anti-HA antibody (Fig. 1C).
3.3. ISBP interacts with the C-terminus of caspase-2S
Caspase-2S is a truncated form of caspase-2 generated by
insertion of a 61 bp intron, resulting in a stop codon 21 amino
acids downstream of the insertion [14]. Hence, the sequence
from 21 amino acids downstream of the active domain
QACRG in caspase-2S is di¡erent from that of caspase-2L.
To investigate the region of caspase-2S that interacts with
ISBP, several pAS2-1 hybrids with mutants of caspase-2S
were co-transformed with pACT2 hybrid with ISBP into the
yeast Y187 strain. The pACT2 hybrid with ISBP interacted
with an N-terminus-lacking mutant (v1^138), but not a mu-
tant lacking the C-terminus (v139^312) or a mutant lacking
21 amino acids from the C-terminus (v292^312) (Fig. 2).
3.4. Detection of ISBP mRNA in human tissues
Although the expression of CIB mRNA has been detected
in some cell lines and platelets [23], it remains unclear whether
CIB is expressed in other tissues. To examine the expression
of ISBP in di¡erent tissues, we performed Northern blot anal-
ysis with a radioactive probe corresponding to the ISBP
cDNA (Fig. 3). ISBP mRNA was found to be expressed in
all adult and embryonic human tissues examined, indicating
that ISBP is probably a ubiquitous protein.
3.5. ISBP partially inhibits caspase activity
To investigate the e¡ects of ISBP on caspase activity, we
used a cell-free system using anti-Fas antibody-induced apop-
totic Jurkat cytosolic lysates. Jurkat cells were induced to
Fig. 2. Interaction of ISBP with caspase-2S deletion mutants. Yeast Y187 cells were co-transformed with expression vector encoding various
caspase-2S deletion mutants fused to the GAL4 DNA-binding domain and ISBP fused to the GAL4 DNA activation domain. Each transform-
ant was analyzed by the L-galactosidase ¢lter assay. The shaded boxes indicate caspase-2S speci¢c sequences.
Fig. 3. Northern blotting analysis of ISBP mRNA in multiple hu-
man tissues. Northern blotting analysis of ISBP mRNA was per-
formed on multiple human adult and embryonic tissues. The same
¢lters were reprobed with L-actin as a control.
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undergo apoptosis in the presence of 250 ng/ml of anti-Fas
antibody for 4 h. Cytosolic extracts treated with anti-Fas anti-
body were isolated and incubated for the indicated times with
35S-labeled pro-caspase-2L translated in vitro in the presence
or absence of recombinant ISBP protein. Cleavage of pro-
caspase-2L into the 14 kDa fragment was induced by apop-
totic Jurkat cytosolic lysate in a time-dependent manner and
this cleavage was signi¢cantly delayed in the presence of ISBP
(Fig. 4).
4. Discussion
The aim of this study was to isolate a protein that may
interact with caspase-2S, which is a truncated form of casp-
ase-2 generated by alternative splicing and antagonizes cell
death, using the yeast two-hybrid system. The isolated cDNA
encoded a polypeptide of 191 amino acids that has recently
been isolated as a protein which binds to the integrin KIIb
cytoplasmic domain, designated as CIB [23]. The integrins
are adhesion molecules and transmembrane glycoproteins
composed of K and L subunits, which mediate the adherence
of cells to the extracellular matrix important for various phys-
iological processes such as homeostasis, angiogenesis, cell pro-
liferation and di¡erentiation [26]. Integrin-mediated adhesion
to the extracellular matrix also plays an important role in
anchorage-dependent cell survival [27,28]. In hematopoietic
cell lines, the induction of apoptosis was caused by ¢bronectin
via its interaction with very late antigen that belongs to the
integrin L1 subfamily [29]. Since it has been reported that CIB
only binds to the cytoplasmic domain of integrin KIIb, but not
other integrin cytoplasmic domains such as Kv, K2, K5, L1 and
L3 [23], it has been speculated that CIB/ISBP is not mainly
involved in the regulation of ¢bronectin-induced cell death.
Furthermore, integrin KIIbL2 functions as the platelet ¢brino-
gen receptor and is speci¢cally expressed in the megakaryo-
cytic lineage. On the other hand, CIB is expressed in platelets.
As platelets do not have nuclei, therefore, it is unlikely that
ISBP is involved in the regulation of cell survival by integrins.
Northern blotting analysis revealed that ISBP is expressed in
all human adult and embryonic tissues examined to date
where the expression of caspase-2S was detected (Fig. 3).
These results suggested that ISBP is a ubiquitous protein
and functions as not only the regulatory molecule for platelet
integrin KIIbL2, but also as a co-factor for the anti-apoptotic
action of caspase-2S.
ISBP is similar to calcineurin B and calmodulin. Calcineu-
rin B is a small regulatory subunit of calcineurin or phospho-
protein phosphatase 2B, and has four EF motifs. Calcineurin
is a hetero dimer that consists of calcineurin A (a large cata-
lytic subunit) and calcineurin B. Calcineurin A binds to cal-
modulin, while calcineurin B binds to four atoms of calcium
[30]. The activity of calcineurin is regulated by calmodulin and
calcium. Calcium signaling is believed to be involved in apop-
tosis in certain pathways such as neuronal death induced by
glutamate, inducers of calcium in£ux and calcineurin activa-
tion, and cell death in T cells [31^33]. Sustained increases in
cytosolic calcium result in the activation of calcineurin and
subsequent apoptosis in susceptible cells [34] and overexpres-
sion of constitutively active calcineurin induced apoptosis in
mammalian cells [35]. These observations and the similarity
between ISBP and calcineurin B raise the possibility that ISBP
is involved in calcium-induced apoptosis as a regulatory sub-
unit for an unknown enzyme or caspase-2S.
Interestingly, in vitro cleavage experiments showed that re-
combinant ISBP has the ability to partially attenuate the pro-
cessing of pro-caspase-2L induced by treatment with anti-Fas
antibody in a cell-free system. This suggested the attenuation
of caspase activation in response to anti-Fas antibody by
ISBP in vitro. However, the mechanism of ISBP-mediated
attenuation of caspases activity is still unclear. Since the C-
terminal 21 amino acids of caspase-2S (a region speci¢c to
caspase-2S, but not caspase-2L) are critical for the interaction
with ISBP, ISBP is unlikely to bind caspase-2L directly.
Hence, the interaction of ISBP with pro-caspase-2L was not
implicated in this inhibition. Moreover, we found that ISBP is
not a substrate for caspases in this cell-free system (data not
shown), indicating that ISBP-mediated suppression of caspase
activity is not due to competition with pro-caspase-2L and
-2S. It has been shown that caspase-2S mRNA is expressed
in Jurkat cells [14]. Therefore, ISBP may attenuate the caspase
activity through its interaction with caspase-2S in the quies-
cent state.
ISBP is the ¢rst candidate molecule to mediate and/or reg-
ulate the cell survival function of caspase-2S. The cell death of
motor neurons during development was increased in caspase-
2-de¢cient mice, suggesting that caspase-2S predominantly
acts as a cell survival factor in some neuronal populations
during development [22]. These results suggested that the in-
teraction of caspase-2S with ISBP may have some role(s) in
apoptosis. Thus, it will be of interest to elucidate the main
machinery of caspase-2S-mediated anti-apoptotic function to
understand embryonic neuronal death.
Fig. 4. The suppressive e¡ect of ISBP on in vitro cleavage of pro-caspase-2L. 1U107/ml Jurkat cells were treated with 250 ng/ml anti-Fas
monoclonal antibody CH-11 for 4 h and cytosolic lysates were prepared as described in Section 2. In vitro translated 35S-labeled pro-caspase-
2L was incubated with cytosolic lysates for the indicated times at 30‡C in the presence or absence of recombinant ISBP protein.
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